XNASRENE
Market cap151mUSD
Jan 10, Last price
11.78USD
1D
0.85%
1Q
2.43%
IPO
18.33%
Name
Cartesian Growth Corporation II
Chart & Performance
Profile
Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | |
Income | |||
Revenues | |||
Cost of revenue | 2,032 | 685 | |
Unusual Expense (Income) | |||
NOPBT | (2,032) | (685) | |
NOPBT Margin | |||
Operating Taxes | (5,614) | ||
Tax Rate | |||
NOPAT | (2,032) | 4,929 | |
Net income | 11,441 8.53% | 10,542 -70,814.18% | |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | (77,437) | 225,400 | |
BB yield | 25.49% | -76.49% | |
Debt | |||
Debt current | 300 | ||
Long-term debt | 3,677 | 3,343 | |
Deferred revenue | |||
Other long-term liabilities | 13,662 | 15,327 | |
Net debt | 3,926 | 2,560 | |
Cash flow | |||
Cash from operating activities | (923) | (843) | |
CAPEX | |||
Cash from investing activities | 77,137 | (236,900) | |
Cash from financing activities | (76,707) | 238,287 | |
FCF | (1,044) | 4,537 | |
Balance | |||
Cash | 51 | 544 | |
Long term investments | 240 | ||
Excess cash | 51 | 783 | |
Stockholders' equity | 155,712 | 221,708 | |
Invested Capital | 173,300 | 239,594 | |
ROIC | 4.11% | ||
ROCE | |||
EV | |||
Common stock shares outstanding | 27,715 | 28,750 | |
Price | 10.96 6.93% | 10.25 | |
Market cap | 303,754 3.08% | 294,688 | |
EV | 307,680 | 297,247 | |
EBITDA | (2,032) | (685) | |
EV/EBITDA | |||
Interest | 5,614 | ||
Interest/NOPBT |